Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Australian shares end lower as financials outweigh property sector gains; NZ flat

Published 02/07/2018, 04:52 pm
Updated 02/07/2018, 05:00 pm
© Reuters.  Australian shares end lower as financials outweigh property sector gains; NZ flat
AXJO
-
CBA
-
ANZ
-
SIG
-

(Updates to close)

By Nikhil Nainan

July 2 (Reuters) - Australian shares edged lower on Monday as financials offset gains in real estate stocks on the first trading day of the country's new financial year.

The S&P/ASX 200 index .AXJO fell 0.3 percent, or 16.8 points, to close at 6,177.8.

Financials tipped the benchmark lower, with Australia and New Zealand Banking ANZ.AX falling 1.5 percent.

On Friday, ANZ said it expects difficult trading conditions to continue for the foreseeable future, amid a damaging public sector inquiry into the country's financial sector. the country's biggest lender Commonwealth Bank of Australia CBA.AX was hit with a class action lawsuit, which accused the bank of failing to disclose widespread breaches of anti-money-laundering rules. CBA ended 0.2 percent lower. stocks bucked the wider decline, with the Australian real estate index .AXRE closing 0.4 percent higher after last week's near 2 percent drop.

"Real estate was sold down hard in the lead up to the end of financial year last week, so that whole sector is bouncing back," said Michael McCarthy, chief strategist at CMC Markets and Stockbroking.

Investors are also closely watching the outcome of Tuesday's Reserve Bank of Australia policy meeting, where the central bank is likely to hold rates, a Reuters poll showed. there is no clarity on how severe U.S.-China trade tensions could become, the RBA is more likely than not to be cautious and assume a dovish tilt, if anything," Mizuho said in a note.

New Zealand's benchmark S&P/NZX 50 index .NZ50 closed flat at the start of the week, as consumer staples and utility stocks offset strong gains in EBOS Group EBO.NZ .

EBOS Group soared to a record high after it snapped up the deal to distribute pharmaceutical products to over 400 Chemist Warehouse and My Chemist stores in Australia from Sigma Healthcare SIG.AX .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.